STROKE's DIRECT COSTS WERE $17 BIL IN 1993 IN U.S.
Executive Summary
STROKE's DIRECT COSTS WERE $17 BIL IN 1993 IN U.S., according to David Matchar, MD, Duke University, head researcher of an HHS Agency for Health Care Policy & Research-funded PORT team. The direct cost estimate includes the cost of physician, hospital stay, rehabilitation and equipment. In addition, $13 bil. was spent in 1993 on indirect costs of stroke including "non-medical costs [such as patient's] loss of productivity," bringing the total cost of stroke in 1993 to $30 bil, Matchar said.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth